{
  "Johnson & Johnson": {
    "2021": {
      "FORM": "8-K",
      "CATEGORIES": {
        "Section 8 - Other Events": {
          "ITEMS": {
            "Item 8.01 - Other Events": {
              "content": "As previously disclosed in Johnson and Johnson’s (the “Company”) most recent Form 10-Q, filed with the Securities and Exchange Commission on April 30, 2021, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $4.7 billion, reducing the award to $2.1 billion regarding various talc cases (the “Ingham verdict”).",
              "subsections": {
                "missouri_supreme_court_appeal": "At that time, the Company filed an application for a transfer of the case to the Missouri Supreme Court. On November 3, 2020 the Missouri Supreme Court announced its decision not to hear the Company’s appeal of the Ingham verdict.",
                "financial_reserve": "As a result, the Company recorded a reserve consistent with the Ingham verdict, which was reflected in its 2020 fiscal year-end results.",
                "us_supreme_court_petition": "The Company petitioned the United States Supreme Court to review the Ingham verdict, which was denied on June 1, 2021.",
                "final_payment": "As a result, the Company will make a $2.5 billion payment, which includes total accrued interest, in June 2021."
              }
            }
          }
        }
      }
    }
  }
}